Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation -two cases report-

다국어 초록 (Multilingual Abstract)

Percutaneous trans-catheter aortic valve implantation (TAVI) is recommended for inoperable patients with severe aortic stenosis at high risk for conventional aortic valve replacement. Originally, TAVI was mostly performed under general anesthesia. Here we describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine. Dexmedetomidine provides sedation, analgesia with minimal respiratory depression. Although MAC during transfemoral TAVI has limitations, such as unexpected patient movement and difficulty in intra-procedural use of transesophageal echocardiography, MAC with dexmedetomidine is feasible with close monitoring, fluoroscopic guidance and the participation of experienced anesthesiologists.

참고문헌 (Reference)

1 Bergmann L, "Transfemoral aortic valve implantation under sedation and monitored anaesthetic care--a feasibility study" 66 : 977-982, 2011

2 Covello RD, "Transcatheter implantation of an aortic valve:anesthesiological management" 76 : 100-108, 2010

3 Ben-Dor I, "Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation" 13 : 207-210, 2012

4 Hammer GB, "The effects of dexmedetomidine on cardiac electrophysiology in children" 106 : 79-83, 2008

5 Cribier A, "Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description" 106 : 3006-3008, 2002

6 Behan M, "Percutaneous aortic valve implants under sedation: our initial experience" 72 : 1012-1015, 2008

7 Candiotti KA, "Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial" 110 : 47-56, 2010

8 Motloch LJ, "Local versus general anesthesia for transfemoral aortic valve implantation" 101 : 45-53, 2012

9 Baan J Jr, "Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis" 159 : 497-503, 2010

10 Snapir A, "Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects" 105 : 902-910, 2006

11 Johansen JW, "Development and clinical application of electroencephalographic bispectrum monitoring" 93 : 1336-1344, 2000

12 Covello RD, "Anesthetic management of percutaneous aortic valve implantation:focus on challenges encountered and proposed solutions" 23 : 280-285, 2009

13 손효정, "Anesthetic considerations of percutaneous transcatheter aortic valve implantation: first attempt in Korea -A report of 2 cases-" 대한마취통증의학회 60 (60): 128-133, 2011

14 Riker RR, "Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit" 25 : S8-S18, 2005

15 Holmes DR Jr, "2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement" 59 : 1200-1254, 2012